T2 Biosystms Stock Price Prediction

TTOO Stock  USD 3.00  0.05  1.64%   
As of today, the RSI of T2 Biosystms' share price is approaching 33. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling T2 Biosystms, making its price go up or down.

Oversold Vs Overbought

33

 
Oversold
 
Overbought
T2 Biosystms stock price prediction is an act of determining the future value of T2 Biosystms shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of T2 Biosystms' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of T2 Biosystms and does not consider all of the tangible or intangible factors available from T2 Biosystms' fundamental data. We analyze noise-free headlines and recent hype associated with T2 Biosystms, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting T2 Biosystms' stock price prediction:
EPS Estimate Next Quarter
(2.79)
EPS Estimate Current Year
(18.52)
EPS Estimate Next Year
(6.36)
Wall Street Target Price
12
EPS Estimate Current Quarter
(3.85)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of T2 Biosystms based on different types of headlines from major news networks to social media. The TTOO stock price prediction module provides an analysis of price elasticity to changes in media outlook on T2 Biosystms over a specific investment horizon. Using T2 Biosystms hype-based prediction, you can estimate the value of T2 Biosystms from the perspective of T2 Biosystms response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards T2 Biosystms using T2 Biosystms' stock options and short interest. It helps to benchmark the overall future attitude of investors towards TTOO using crowd psychology based on the activity and movement of T2 Biosystms' stock price.

T2 Biosystms Implied Volatility

    
  0.0  
T2 Biosystms' implied volatility exposes the market's sentiment of T2 Biosystms stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if T2 Biosystms' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that T2 Biosystms stock will not fluctuate a lot when T2 Biosystms' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in T2 Biosystms. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in T2 Biosystms to buy its stock at a price that has no basis in reality. In that case, they are not buying TTOO because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

T2 Biosystms after-hype prediction price

    
  USD 2.93  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out T2 Biosystms Basic Forecasting Models to cross-verify your projections.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of T2 Biosystms' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.224.3911.89
Details
Naive
Forecast
LowNextHigh
0.073.2610.76
Details
1 Analysts
Consensus
LowTargetHigh
7.908.689.63
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-4.63-2.2-4.63
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as T2 Biosystms. Your research has to be compared to or analyzed against T2 Biosystms' peers to derive any actionable benefits. When done correctly, T2 Biosystms' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in T2 Biosystms.

T2 Biosystms After-Hype Price Prediction Density Analysis

As far as predicting the price of T2 Biosystms at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in T2 Biosystms or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of T2 Biosystms, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

T2 Biosystms Estimiated After-Hype Price Volatility

In the context of predicting T2 Biosystms' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on T2 Biosystms' historical news coverage. T2 Biosystms' after-hype downside and upside margins for the prediction period are 0.15 and 10.43, respectively. We have considered T2 Biosystms' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.00
2.93
After-hype Price
10.43
Upside
T2 Biosystms is very risky at this time. Analysis and calculation of next after-hype price of T2 Biosystms is based on 3 months time horizon.

T2 Biosystms Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as T2 Biosystms is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading T2 Biosystms backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with T2 Biosystms, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.70 
7.50
  0.07 
  0.09 
9 Events / Month
7 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.00
2.93
2.33 
7,500  
Notes

T2 Biosystms Hype Timeline

T2 Biosystms is at this time traded for 3.00. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.09. TTOO is estimated to decline in value after the next headline, with the price expected to drop to 2.93. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.33%, whereas the daily expected return is at this time at -0.7%. The volatility of related hype on T2 Biosystms is about 6081.08%, with the expected price after the next announcement by competition of 2.91. About 22.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 35.62. T2 Biosystms had not issued any dividends in recent years. The entity had 1:100 split on the 13th of October 2023. Given the investment horizon of 90 days the next estimated press release will be in about 9 days.
Check out T2 Biosystms Basic Forecasting Models to cross-verify your projections.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

T2 Biosystms Related Hype Analysis

Having access to credible news sources related to T2 Biosystms' direct competition is more important than ever and may enhance your ability to predict T2 Biosystms' future price movements. Getting to know how T2 Biosystms rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how T2 Biosystms may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GHGuardant Health(0.13)11 per month 0.00 (0.22) 4.38 (4.92) 18.62 
LHLaboratory(1.03)10 per month 0.00 (0.14) 1.93 (2.47) 5.45 
MDXHMDxHealth SA ADR(0.76)7 per month 0.00 (0.15) 5.28 (8.77) 25.16 
MEDPMedpace Holdings 0.40 11 per month 1.07  0.12  3.13 (1.94) 14.24 
DMTKDermTech(0.05)7 per month 0.00 (0.18) 5.69 (8.24) 51.02 
BIAFWBioAffinity Technologies Warrant 0.00 1 per month 18.78  0.26  89.41 (47.10) 184.28 
VNRXVolitionrx 0.12 6 per month 6.37  0.04  10.48 (9.35) 63.94 
MYGNMyriad Genetics 0.33 12 per month 2.72 (0.01) 5.17 (4.47) 17.90 
MYNZMainz Biomed BV 0.01 9 per month 0.00 (0.05) 5.83 (6.96) 31.96 

T2 Biosystms Additional Predictive Modules

Most predictive techniques to examine TTOO price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TTOO using various technical indicators. When you analyze TTOO charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About T2 Biosystms Predictive Indicators

The successful prediction of T2 Biosystms stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as T2 Biosystms, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of T2 Biosystms based on analysis of T2 Biosystms hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to T2 Biosystms's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to T2 Biosystms's related companies.
 2021 2022 2023 2024 (projected)
Days Of Sales Outstanding66.7935.440.738.67
Days Of Inventory Outstanding68.9275.0986.3679.05

Story Coverage note for T2 Biosystms

The number of cover stories for T2 Biosystms depends on current market conditions and T2 Biosystms' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that T2 Biosystms is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about T2 Biosystms' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

T2 Biosystms Short Properties

T2 Biosystms' future price predictability will typically decrease when T2 Biosystms' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of T2 Biosystms often depends not only on the future outlook of the potential T2 Biosystms' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. T2 Biosystms' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding51 K
Cash And Short Term Investments10.3 M
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out T2 Biosystms Basic Forecasting Models to cross-verify your projections.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for TTOO Stock analysis

When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.62)
Revenue Per Share
7.933
Quarterly Revenue Growth
(0.60)
Return On Assets
(0.68)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.